A shelf of drugs at a pharmacy in Quebec City on March 8, 2012. Critics of a major drug-price overhaul hope a new federal cabinet will put a temporary stop to the new regulations set to come into effect in January. The Patented Medicine Prices Review Board is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug prices. THE CANADIAN PRESS/Jacques Boissinot

A shelf of drugs at a pharmacy in Quebec City on March 8, 2012. Critics of a major drug-price overhaul hope a new federal cabinet will put a temporary stop to the new regulations set to come into effect in January. The Patented Medicine Prices Review Board is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug prices. THE CANADIAN PRESS/Jacques Boissinot

Critics hope Trudeau’s new cabinet will put a stop to drug-price regulation changes

Overhaul has drawn the disapproval of patient groups and drug manufacturers

Critics of a major drug-price overhaul hope a fresh federal cabinet will put a temporary stop to the new regulations set to take effect in January.

The Patented Medicine Prices Review Board is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug costs.

Several groups, including a coalition of eight Canadian life-sciences organizations, have written to government ministers to ask them to put off the changes pending more consultation, input from the new federal cabinet, and the resolution of several legal challenges.

The overhaul has drawn the disapproval of patient groups and drug manufacturers, as well as some pharmacists, doctors, academics and even provincial governments.

While most welcome more affordable drugs, some critics fear a drastic drop in the sticker price for medicines will make Canada an unattractive place to launch new products, which could leave life-saving therapies out of reach for Canadian patients.

Health Canada says the implementation of the changes has already been delayed several times, and the government is committed to increasing the affordability, accessibility and appropriate use of medicines for Canadians.

—The Canadian Press

RELATED: As world waits for COVID-19 therapy, U.S. warily eyes Canada’s drug-price plans

RELATED: B.C. mom’s drug-pricing petition on behalf of son garners thousands of signatures

DrugsFederal Politicspharmacare plan

Be Among The First To Know

Sign up for a free account today, and receive top headlines in you inbox Monday to Saturday.

Sign Up with google Sign Up with facebook

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Reset your password

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

A link has been emailed to you - check your inbox.



Don't have an account? Click here to sign up